[HTML][HTML] Androgen receptor-dependent and-independent mechanisms involved in prostate cancer therapy resistance
DJ Crona, YE Whang - Cancers, 2017 - mdpi.com
Despite the initial efficacy of androgen deprivation in prostate cancer, virtually all patients
progress to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) signaling …
progress to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) signaling …
[PDF][PDF] Androgen Receptor-Dependent and-Independent Mechanisms Involved in Prostate Cancer Therapy Resistance
DJ Crona, YE Whang - core.ac.uk
Despite the initial efficacy of androgen deprivation in prostate cancer, virtually all patients
progress to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) signaling …
progress to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) signaling …
[引用][C] Androgen Receptor-Dependent and-Independent Mechanisms Involved in Prostate Cancer Therapy Resistance
D Crona, Y Whang - Cancers, 2017 - cir.nii.ac.jp
Androgen Receptor-Dependent and -Independent Mechanisms Involved in Prostate Cancer
Therapy Resistance | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
Therapy Resistance | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
Androgen Receptor-Dependent and-Independent Mechanisms Involved in Prostate Cancer Therapy Resistance.
DJ Crona, YE Whang - Cancers, 2017 - search.ebscohost.com
Despite the initial efficacy of androgen deprivation in prostate cancer, virtually all patients
progress to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) signaling …
progress to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) signaling …
Androgen Receptor-Dependent and-Independent Mechanisms Involved in Prostate Cancer Therapy Resistance
DJ Crona, YE Whang - Cancers, 2017 - cdr.lib.unc.edu
Despite the initial efficacy of androgen deprivation in prostate cancer, virtually all patients
progress to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) signaling …
progress to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) signaling …
Androgen Receptor-Dependent and-Independent Mechanisms Involved in Prostate Cancer Therapy Resistance.
DJ Crona, YE Whang - Cancers, 2017 - europepmc.org
Despite the initial efficacy of androgen deprivation in prostate cancer, virtually all patients
progress to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) signaling …
progress to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) signaling …
[PDF][PDF] Androgen Receptor-Dependent and-Independent Mechanisms Involved in Prostate Cancer Therapy Resistance
DJ Crona, YE Whang - pdfs.semanticscholar.org
Despite the initial efficacy of androgen deprivation in prostate cancer, virtually all patients
progress to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) signaling …
progress to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) signaling …
Androgen Receptor-Dependent and-Independent Mechanisms Involved in Prostate Cancer Therapy Resistance
DJ Crona, YE Whang - Cancers, 2017 - pubmed.ncbi.nlm.nih.gov
Despite the initial efficacy of androgen deprivation in prostate cancer, virtually all patients
progress to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) signaling …
progress to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) signaling …
[HTML][HTML] Androgen Receptor-Dependent and-Independent Mechanisms Involved in Prostate Cancer Therapy Resistance
DJ Crona, YE Whang - Cancers, 2017 - ncbi.nlm.nih.gov
Despite the initial efficacy of androgen deprivation in prostate cancer, virtually all patients
progress to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) signaling …
progress to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) signaling …
Androgen Receptor-Dependent and-Independent Mechanisms Involved in Prostate Cancer Therapy Resistance
DJ Crona, YE Whang - Cancers, 2017 - search.proquest.com
Despite the initial efficacy of androgen deprivation in prostate cancer, virtually all patients
progress to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) signaling …
progress to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) signaling …